Health Innovation

Over the last century, America evolved a patchwork health care system characterized by coverage gaps, high costs and uneven quality. In a new century, our challenge is to create a high-quality, low-cost health system for all. Innovation is the key. It’s time to retire an obsolete fee-for-service payment system that rewards more, not better, medical services, and replace it with strong incentives for preventive care and healthier lifestyles. We need to lower bureaucratic obstacles and encourage development of breakthrough cures, treatments and devices. Crucially, we need to equip all Americans with new, high-tech tools that enable them to monitor their own health and enhance the productivity of health-care workers.

But instead of focusing on modernizing our health care system, Washington policymakers are mired in yesterday’s ideological battles and the American people are seeing costs rise in a complex system that doesn’t always help them get the care they need. PPI’s Health Innovation Project highlights new ideas for creating a distinctively American approach to universal coverage and high-quality health care – one that is decentralized, powered by the ingenuity of our inventors, entrepreneurs and workers, and disciplined by both market competition and strong public oversight.

Publications

By and / 11.14.2018

The Progressive Policy Institute (PPI) today released a national opinion survey that highlights the surprising resilience of America’s pragmatic political center two years into Donald Trump’s deeply polarizing presidency. The poll reinforces a key takeaway from the 2018 midterm elections: Suburban voters – especially women – are repelled by the president’s racial and cultural demagoguery […]

By / 10.24.2018

“Millions of our citizens do not now have a full measure of opportunity to achieve and enjoy good health. Millions do not now have protection or security against the economic effects of sickness. The time has arrived for action to help them attain that opportunity and that protection.” –President Harry Truman, 1945

By / 10.3.2018

Carl Icahn, the billionaire businessman and investor, recently advised shareholders to reject Cigna’s proposed $67 billion acquisition of the pharmacy benefit manager (PBM) Express Scripts. He says that a reckoning is coming for PBMs and that the price grossly exaggerated their value as “over-earning middle men.” In 2016, PBMs made $23 billion in gross profits […]

Press

Last week, the Centers for Medicare and Medicaid Services (CMS) announced that it had approved a reinsurance proposal in Wisconsin and Maine in an effort to keep health premiums down. Reinsurance is essentially insurance for insurers: The government helps pay for the cost of exceptionally high-cost claims. It’s no wonder states have been working on […]

By / 7.11.2018

President Trump’s nomination of Judge Brett Kavanaugh to fill the seat on the Supreme Court vacated by Justice Anthony Kennedy have left many to wonder: What will replacing an often swing vote with a more conservative one mean for health care? There are many pending cases in lower courts that, if they make it a […]

By / 6.20.2018

Two weeks ago, the U.S. Department of Justice (DOJ) filed a legal brief in support of a Texas lawsuit that would kill one of the most popular provisions of the Affordable Care Act (ACA): the one that ensures people with past medical problems can get affordable health insurance. It’s the latest twist in the Trump administration’s unrelenting […]

Blog

By / 11.19.2018

Health care costs continue to be top of mind for a plurality of voters, according to a recent poll by PPI and Expedition Strategies. Our poll surveyed 1,090 likely voters on to gather data to apply context and to for what kind of agenda progressives should craft as the 2020 election cycle dawns. Health care […]

By / 8.28.2018

The drug industry, like any industry, has its share of bad actors. The loathsome Martin Shkreli is now serving time after his company, Turing Pharmaceuticals, jacked up the cost of a lifesaving AIDS drug by 5,000 percent. Mylan, a Dutch company, was caught overcharging the federal Medicaid program $1.27 billion for EpiPens, used to protect […]

By / 8.3.2018

President Trump promised Americans cheaper and better health care than what is provided under the Affordable Care Act (ACA). Yet his latest move, to expand access to short-term, limited-duration health plans, may make insurance cheaper but far from better. These short-term plans have existed under the ACA as a short-term stop-gap measure for people in […]